NCT04780074View on ClinicalTrials.gov

Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2021

Primary Completion Date

May 21, 2021

Study Completion Date

December 13, 2022

Conditions
Bioavailability of Coenzyme Q10
Interventions
DIETARY_SUPPLEMENT

Single dose intervention with Standard product (SP)

2 capsules - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP1)

2 softgels - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP2)

2 softgels - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP3)

2 softgels - 200 mg total CoQ10

DIETARY_SUPPLEMENT

Single dose intervention with Investigational product (IP4)

2 capsules - 200 mg total CoQ10

Trial Locations (1)

1000

ADM, ambulanta družinske medicine, Ljubljana, Slovenia, Ljubljana

All Listed Sponsors
collaborator

Vizera d.o.o.

INDUSTRY

collaborator

ADM, Ambulanta družinske medicine, Ljubljana, Slovenia

UNKNOWN

collaborator

Adrialab d.o.o., Ljubljana, Slovenia

UNKNOWN

collaborator

Tishcon Corp., USA

UNKNOWN

lead

Institute of Nutrition, Slovenia (Nutris)

OTHER

NCT04780074 - Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations | Biotech Hunter | Biotech Hunter